musculoskeletal

Kaia Health gets $75m for digital solution to strains and pains of pandemic workplace

  • by

Kaia Health has just announced a $75 million funding round for its technology, aimed at improving musculoskeletal (MSK) and chronic obstructive pulmonary disease (COPD) care. Founder and CEO Konstantin Mehl spoke to pharmaphorum’s news editor Richard Staines about why these treatments will be in demand… Read More »Kaia Health gets $75m for digital solution to strains and pains of pandemic workplace